Jarosław Sławek Selected Research

galanin-(1-13)-bradykinin-(2-9)-amide (M 35)

11/2008	The influence of vascular risk factors and white matter hyperintensities on the degree of cognitive impairment in Parkinson's disease.
12/2006	Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jarosław Sławek Research Topics

Disease

25	Parkinson Disease (Parkinson's Disease) 08/2022 - 01/2003
9	Cognitive Dysfunction 07/2021 - 12/2006
8	Dementia (Dementias) 07/2021 - 01/2003
7	Parkinsonian Disorders (Parkinsonism) 01/2022 - 01/2003
6	Dyskinesias (Dyskinesia) 01/2022 - 01/2003
6	Dystonia (Limb Dystonia) 01/2022 - 01/2003
6	Torticollis (Wryneck) 01/2021 - 01/2002
4	Pain (Aches) 01/2022 - 05/2005
3	Fabry Disease (Fabry's Disease) 01/2021 - 01/2020
3	Infections 01/2021 - 07/2014
3	Movement Disorders (Movement Disorder) 01/2020 - 01/2006
2	Huntington Disease (Huntington's Disease) 01/2022 - 01/2017
2	Cerebral Palsy (Spastic Diplegia) 01/2021 - 03/2005
2	COVID-19 01/2021 - 01/2021
2	Ataxia (Dyssynergia) 01/2019 - 01/2015
2	Alzheimer Disease (Alzheimer's Disease) 08/2018 - 01/2013
2	Multiple Sclerosis 01/2017 - 09/2003
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013 - 12/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2012 - 07/2006
2	Neuralgia (Stump Neuralgia) 01/2006 - 05/2005
1	Restless Legs Syndrome (Restless Legs) 08/2022
1	Tremor (Tremors) 01/2022
1	Chorea (Rheumatic Chorea) 01/2022
1	Migraine Disorders (Migraine) 01/2022
1	Hyperhomocysteinemia 03/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Orthostatic Hypotension (Postural Hypotension) 01/2021
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2021
1	Dystonic Disorders (Writer's Cramp) 01/2020
1	Diplopia (Double Vision) 01/2020
1	Hallucinations (Hallucination) 01/2020
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Atrial Fibrillation 01/2019
1	Primary Progressive Nonfluent Aphasia (Progressive Nonfluent Aphasia) 12/2018
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 12/2018
1	Glycogen Storage Disease Type II (Pompe's Disease) 01/2017
1	Constipation 01/2017
1	Confusion (Bewilderment) 01/2017
1	Psychotic Disorders (Schizoaffective Disorder) 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Sialorrhea 01/2017
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 01/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Polyneuropathies (Polyneuropathy) 12/2016
1	Apraxias (Dyspraxia) 01/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2015
1	Tuberculosis (Tuberculoses) 01/2015
1	Autonomic Nervous System Diseases (Dysautonomia) 01/2015
1	Discitis 01/2015
1	Paralysis (Palsy) 01/2015
1	Atrophy 01/2013
1	Stroke (Strokes) 07/2010
1	Disease Progression 07/2010

Drug/Important Bio-Agent (IBA)

16	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 01/2003
5	Botulinum Toxins (Botulinum Toxin)IBA 01/2021 - 01/2002
4	Type A Botulinum Toxins (Botox)FDA Link 01/2022 - 01/2002
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2002
3	incobotulinumtoxinA FDA Link 01/2022 - 01/2021
3	HomocysteineIBA 01/2013 - 10/2012
3	Apomorphine FDA Link 10/2006 - 01/2003
2	Apolipoproteins E (ApoE)IBA 03/2021 - 08/2018
2	ApolipoproteinsIBA 03/2021 - 08/2018
2	galanin-(1-13)-bradykinin-(2-9)-amide (M 35)IBA 11/2008 - 12/2006
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	CannabinoidsIBA 01/2022
1	Calcitonin Gene-Related PeptideIBA 01/2022
1	AngiotensinogenIBA 07/2021
1	Angiotensin IIIBA 07/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2021
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 03/2021
1	GalactosidasesIBA 01/2021
1	migalastatIBA 01/2021
1	hydroxide ionIBA 01/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019
1	AnticoagulantsIBA 01/2019
1	ProgranulinsIBA 12/2018
1	Protein Isoforms (Isoforms)IBA 08/2018
1	Apolipoprotein E4IBA 08/2018
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2017
1	human GAA protein (Myozyme)FDA Link 01/2017
1	Mitochondrial DNA (mtDNA)IBA 01/2017
1	AntigensIBA 07/2014
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2014
1	Presenilin-1IBA 01/2013
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2012
1	Dopamine Agonists (Dopamine Agonist)IBA 07/2010

Therapy/Procedure

14	Therapeutics 01/2021 - 01/2003
7	Deep Brain Stimulation 08/2022 - 01/2006
6	Injections 01/2021 - 01/2002
3	Enzyme Replacement Therapy 01/2021 - 01/2020
2	Immunotherapy 01/2021 - 01/2015
2	Radiotherapy 01/2020 - 01/2020
2	Activities of Daily Living (ADL) 09/2011 - 07/2010
1	Home Nursing (Nursing, Home) 01/2021
1	Long-Term Care 01/2021
1	Telescopes 01/2020